National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

No judgment structure available for this case.

STATUTORY RULES.

1960. No. 90

_________

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1959.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1959.

Dated this Twenty Seventh day of October, 1960.

DUNROSSIL

Governor-General.

By His Excellency’s Command,

(Sgd) Donald A. Cameron

Minister of State for Health.

______

AMENDMENTS OF THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS.

Commencement.

1. These Regulations shall come into operation on the first day of November, 1960.

Interpretation.

2.Regulation 5 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting from sub-regulation (1.) the definition of “authorized prescription form” and inserting in its stead the following definition:—

“ ‘approved hospital’ means a hospital the governing body of which is an approved hospital authority;”.

3.Regulation 19 of the National Health (Pharmaceutical Benefits Regulations is repealed and the following regulation inserted in its stead:—

Writing of prescriptions.

“19.—(1.) A prescription is not duly written unless the medical practitioner concerned—

(a) writes the prescription in ink in his own handwriting, or with the approval of the Director-General otherwise records the prescription, upon a paper as near as is convenient to six inches in length and four inches in breadth on which appear the name and address of the medical practitioner and at the top of which appear the letters ‘N.H.S.’;
(b) makes out the prescription in duplicate, the duplicate being marked with the word ‘Duplicate’;
(c) specifies on the prescription the date on which the prescription is written and signs the prescription;
(d) states in the prescription the name of the person for whom the pharmaceutical benefit is to be supplied and, except where that person is a pensioner, the address of that person;

–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––

*Notified in the Commonwealth Gazette on 28th October, 1960.

Statutory Rules 1960, No. 17.

7276/60.—PRICE 8D. 9/14.10.1960.

(e) identifies in the prescription the pharmaceutical benefit by such particulars as are necessary for the complete identification of the pharmaceutical benefit;
(f) if the prescription is for the supply of a pharmaceutical benefit to a pensioner—marks the prescription with the pension number appearing on an entitlement card issued to the pensioner, or to a pensioner of whom that pensioner is a dependant, by the Commonwealth for the purposes of Part IV. and Part VII. of the Act;
(g) if the pharmaceutical benefit to be supplied consists of a single drug—indicates in the prescription the manner in which the pharmaceutical benefit is to be administered;
(h) if the prescription is for the supply of a pharmaceutical benefit specified in the Fifth Schedule and is written by virtue of the fact that it is for a purpose, disease or condition, or that the person for whom it is written is included in a class of persons other than pensioners, specified in that Schedule in relation to the pharmaceutical benefit—marks the prescription in his own handwriting with the words ‘Specified purpose’ or with an abbreviation of those words; and
(i) if the medical practitioner, in pursuance of regulation 24 of these Regulations, directs in the prescription the supply on the one occasion of a quantity or number of units of a pharmaceutical benefit exceeding the quantity or number of units that could otherwise be prescribed—marks the prescription in his own handwriting with the words ‘Regulation 24’.

“(2.) Notwithstanding compliance with the last preceding sub-regulation, a prescription is not duly written by a medical practitioner if the prescription contains—

(a) a prescription for the supply to a person of a pharmaceutical benefit for the supply of which to the same person another prescription has been written by the same medical practitioner on the same day;
(b) prescriptions for pharmaceutical benefits for more than one person; or
(c) a prescription for a pharmaceutical benefit that is a dangerous drug and also a prescription for another pharmaceutical benefit, if the prescription directs that one or both of those pharmaceutical benefits is or are to be supplied more than once.

“(3.) In this regulation, ‘dangerous drug’ means a drug or medicinal preparation in respect of which the law of the State or Territory in which the prescription is written provides that a pharmaceutical chemist who dispenses that drug or medicinal preparation, or who dispenses it on the last of a number of occasions of supply indicated in a prescription for its supply, shall take possession of the prescription and cancel it or deliver it to the authority administering that law.”.

Supply of pharmaceutical benefits on prescriptions.

4. Regulation 21 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting from paragraph (b) the words “on an authorized prescription form”.

Supply of pharmaceutical benefit on first presentation of prescription.

5.Regulation 23 of the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting from paragraphs (a) and (c) the words “authorized prescription form” and inserting in their stead the word “prescription”;
(b) by adding at the end of paragraph (a) the word “and”; and
(c) by omitting paragraph (b).

Receipts.

6. Regulation 31 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting from sub-regulations (1.) and (3.) the words “authorized prescription form” and inserting in their stead the word “prescription”.

First, Second and Third Schedules.

7. The First, Second and Third Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

Regulation 10.

FIRST SCHEDULE.

DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA THAT ARE NOT TO BE SUPPLIED AS, OR USED IN, PHARMACEUTICAL BENEFITS EXCEPT AS SPECIALLY PROVIDED.

Absorbable Gelatines Sponge.	Cinnamon Oil.
Acetazolamide.	Cinnamon Water, concentrated.
Acetomenaphthone.	Cochineal.
Adrenaline Acid Tartrate.	Colchicine.
Alcohol.	Coriander.
Amethocaine Injection.	Coriander Oil.
Amodiaquine Hydrochloride.	Corticotrophin.
Amphetamine.	Cresol.
Amphetamine Sulphate.	Cyanocobalamin.
Amylobarbitone.	Cyclobarbitone.
Anise Oil.	Cyclopropane.
Antimony Potassium Tartrate.	Dapsone.
Antimony Sodium Tartrate.	Dexamphetamine Sulphate.
Apomorphine Hydrochloride.	Dextran Injection.
Azovan Blue.	Dextran Sulphate.
Bacillus Calmette-Guerin Vaccine.	Dextran Sulphate Injection.
Benzhexol Hydrochloride.	Diethylcarbamazine Citrate.
Bismuth Oxychloride.	Dihydrostreptomycin Sulphate.
Bismuth Sodium Tartrate.	Diiodohydroxyquinoline.
Butobarbitone.	Dill Oil.
Calciferol.	Dill Water, concentrated.
Camphor Water.	Dimercaprol.
Caraway.	Diodone Injection.
Carbachol.	Dithranol.
Carbimazole.	Emetine and Bismuth Iodide.
Carbon Dioxide.	Emetine Hydrochloride.
Cardamom Fruit.	Ergometrine Maleate.
Catgut, sterilized surgical.	Ether Anaesthetic.
Cellulose Oxidized.	Ether Solvent.
Chlorcyclizine Hydrochloride.	Ether Vinyl.
Chloroform.	Ethinyloestradiol.
Chloroform Spirit.	Ethisterone.
Chloroform Water.	Ethopropazine Hydrochloride.
Chloroquine Phosphate.	Ethyl Biscoumacetate.
Chloroquine Sulphate.	Ethyl Chloride.
Chloroxylenol.	Ethylenediamine Hydrate.
Chorionic Gonadotropin.	Gallamine Triethiodide.
Cinchocaine Hydrochloride.	Gallamine Injection.
Cinnamon.	Gentian.

FIRST SCHEDULE—continued.

Ginger.	Nitrous Oxide.
Ginger Syrup.	Nux Vomica.
Hamamelis.	Oestradiol Benzoate.
Helium.	Opium.
Heparin.	Opium, powdered.
Hexamethonium Tartrate.	Orange Peel, dried bitter.
Histamine Acid Phosphate.	Orange Peel, fresh bitter.
Human Blood, whole.	Orange Tincture.
Human Red Blood Corpuscles, concentrated.	Orange syrup.
Human Fibrin Foam.	Ouabain.
Human Fibrinogen.	Oxygen.
Human Gamma Globulin.	Oxytetracycline Dihydrate.
Human Gamma Globulin Injection.	Paramethadione.
Human Serum, dried.	Pentamidine Injection.
Human Serum, liquid.	Pentamidine Isethionate.
Human Plasma, dried.	Peppermint Oil.
Human Thrombin.	Peppermint Water, concentrated.
Hydrocortisone Acetate.	Peppermint Spirit.
Hydrocortisone Acetate Ointment.	Pethidine Tablets.
Hydrocortisone Ointment.	Phenindamine Tartrate.
Hydrogen Peroxide Solution, strong.	Phenindione.
Hyoscine. Eve Ointment.	Pheniodol.
Hyoscyamus.	Phenolphthalein Tablets.
Iodised Oil Injection.	Phenolsulphonphthalein.
Iodoxyl.	Picrotoxin.
Iopanoic Acid.	Prednisone Acetate.
Iopanoic Acid Tablets.	Primaquine Phosphate.
Ipecacuanha.	Primidone.
Ipecacuanha. Prepared.	Procyclidine Hydrochloride.
Isoniazid.	Procaine and Adrenaline Injection.
Lead Acetate.	Progesterone.
Lead Monoxide.	Proguanil Hydrochloride.
Lemon Peel, dried.	Propylene Glycol.
Lemon Peel, fresh.	Propyliodone.
Lemon Tincture.	Propyliodone Injection.
Lemon Syrup.	Propyliodone Oily Injection.
Leptazol.	Propyl Thiouracil.
Lignocaine and Adrenaline Injection.	Pyrimethamine.
Lignocaine Hydrochloride	Pyrimethamine Tablets.
Lignocaine Hydrochloride Injection.	Quillaia.
Liquorice Liquid Extract.	Rosemary Oil.
Lucanthone Hydrochloride.	Senna Leaf.
Male Fern.	Soda Lime.
Maleic Acid.	Sodium Antimonylgluconate.
Mannitol.	Sodium Antimonygluconate Injection.
Mepacrine Hydrochloride.	Sodium Aurothiomalate.
Mephenesin.	Sodium Radio-iodide (183I) Injection.
Mephenesin Injection.	Sodium Radio-iodide (181I) Solution.
Mercuric Oxide, yellow.	Sodium Radiophosphate (82P) Injection.
Mercury.	Sodium Radiophosphate (82P) Solution.
Mersalyl Acid.	Sodium Stibogluconate.
Methadone Hydrochloride.	Sodium Stibogluconate Injection.
Methoin.	Solapsone.
Methylated Spirits, industrial.	Solapsone Tablets.
Methyltestosterone.	Stibophen.
Methylamphetamine Hydrochloride.	Sucrose.
Methythiouracil.	Sulphadimidine Sodium.
Mustine Hydrochloride.	Suramin.
Nalorphine Hydrobromide.	Suxamethonium Bromide.
Naphazoline Nitrate.	Suxamethonium Chloride.
Neostigmine Bromide.	Suxamethonium Chloride Injection.
Neostigmine Methylsulphate.	Syrup.
Nicotinic Acid.	Testosterone.
Nikethamide.	Tetrachloroethylene.
Tetracycline Injection.

FIRST SCHEDULE—continued.
Thiomersal.	Tuberculin, old.
Thiopentone Sodium.	Tuberculin Purified Protein Derivative.
Thiopentone Injection.	Tubocurarine Chloride.
Thyroid.	Tubocurarine Injection.
Thyroxine Sodium.	Typhoid-Paratyphoid A and B and Tetanus Vaccine.
Tolazoline Hydrochloride.	Vanillin.
Tolu Syrup.	Yellow Fever Vaccine.
Trichloroethylene.
Tryparsamide.

___________

SECOND SCHEDULE.

Regulation 10 (3.).

DRUGS AND MEDICINAL PREPARATIONS THAT ARE PHARMACEUTICAL BENEFITS ONLY WHEN PRESCRIBED FOR use IN A DETERMINED FORM OR IN ALLOWABLE COMPOUNDS.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Acetone B.P.C.................................................................	Zinc Sulphate B.P. with Sulphurated Potash B.P.C., Acetone B.P.C., Glycerin B.P. and Distilled Water B.P. Magenta B.P.C. with Boric Acid B.P., Phenol B.P., Resorcinol B.P., Acetone B.P.C., Industrial Methylated Spirits B.P. and Water
Dried Aluminium Hydroxide Gel. B.P.......................	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Aluminium Hydroxide Gel. B.P..................................	Aluminium Hydroxide Gel. B.P. with Light Magnesia B.P.
Aluminium Powder........................................................	Aluminium Powder with Zinc Oxide B.P. and Liquid Paraffin B.P.
Aneurine Hydrochloride B.P. ......................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Ascorbic Acid B.P..........................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Bacitracin B.P.................................................................	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base Bacitracin B.P. with Ophthalmic Phosphate Buffer Solution Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P.
Benethamine Penicillin..................................................	Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Benzalkonium Chloride................................................
Benzathine Penicillin B.P.............................................	Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin B.P......................................................	Fortified Procaine Penicillin Injection B.P. Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin Sodium B.P.......................................	Streptomycin Sulphate B.P. with Benzylpenicillin Sodium B.P. Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.

SECOND SCHEDULE—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Bismuth Subnitrate B.P.C.............................................	Resorcinol B.P. with Bismuth Subnitrate B.P.C., Zinc Oxide B.P., Starch B.P., Cade Oil B.P., Wool Fat B.P., Sodium Metabisulphite, Water, Hard Paraffin B.P. and Yellow Soft Paraffin B.P.
Carbromal B.P................................................................	Pentobarbitone Sodium B.P. with Carbromal B.P.
Chloramphenicol B.P.....................................................	Chloramphenicol B.P. with Borate Buffer and Sterile Distilled Water Chloramphenicol B.P. with Propylene Glycol B.P. Chloramphenicol B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Chlorpromazine Hydrochloride B.P............................	—
Chlortetracycline Calcium............................................	—
Chlortetracycline Hydrochloride B.P..........................	Chlortetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Oil of Citronella..............................................................	Dicophane B.P. with Emulsifying Wax B.P., Xylene B.P.C 1949, Oil of Citronella and Water
Clemizole.........................................................................	—
Cortisone Acetate B.P. .................................................	—
Demethylchlortetracycline Hydrochloride................	—
Dienoestrol B.P. ............................................................	—
Diphtheria and Pertussis Vaccine B.P........................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Diphtheria Vaccine B.P.................................................	Diphtheria and Pertussis Vaccine B.P.
Diphtheria, Tetanus and Pertussis Vaccine B.P.
Diphtheria Vaccine B.P. with Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed
Ergotamine Tartrate B.P...............................................	Ergotamine Tartrate B.P. with Caffeine B.P.
Erythromycin B.P...........................................................	—
Hamamelis Dry Extract................................................	Hamamelis Dry Extract with Zinc Oxide B.P. and Theobroma Oil B.P.
Hydrocortisone B.P........................................................	—
Isoprenaline Hydrochloride..........................................	—
Lofenalac........................................................................	—
Mercuric Oxide Eye Ointment B.P.............................	—
Naphazoline....................................................................	Antazoline Hydrochloride B.P. with Naphazoline
Neomycin Sulphate B.P................................................	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P.
Nicotinamide B.P...........................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Oestrone...........................................................................	—
Oleandomycin................................................................	Tetracycline with Oleandomycin
Oleoresin Capsicum......................................................	Bile Salts with Cascara Sagrada B.P., Phenolphthalein B.P. and Oleoresin Capsicum
Oxytetracycline Hydrochloride B.P............................	Oxytetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Papaveretum B.P.C........................................................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Pancreatin B.P.................................................................	—
Pentolinium Tartrate B.P..............................................	Pentolinium Tartrate B.P. with Ephedrine B.P.
Pethidine Hydrochloride B.P.	Pethidine Hydrochloride B.P. with Hyoscine Hydrobromide B.P.
Pertussis Vaccine B.P....................................................	Diphtheria, Tetanus and Pertussis Vaccine B.P. Diphtheria and Pertussis Vaccine B.P.
Phenoxymethylpenicillin B.P.......................................		—

SECOND SCHEDULE—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Phenoxymethylpenicillin (Benzathine Salt)...............	—
Phenoxymethylpenicillin (Calcium Salt)....................	—
Phenoxymethylpenicillin (Hydrabamine Salt)...........	—
Phenoxymethylpenicillin (Potassium Salt).................	—
Phenylephrine Hydrochloride B.P................................	Phenylephrine Hydrochloride B.P. with Benzocaine B.P., Bismuth Subgallate, Zinc Oxide B.P., Hamamelis Dry Extract, Tannic Acid B.P., Menthol B.P., Boric Acid B.P., and Oil of Theobroma B.P.
Polymyxin B. Sulphate B.P...........................................	Polymyxin B. Sulphate B.P. with Mucilage of Methylcellulose and Distilled Water B.P. Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base Polymyxin B. Sulphate B.P. with Ophthalmic Phosphate Buffer Polymyxin B. Sulphate B.P. with Acetic Acid B.P. and Propylene Glycol B.P. Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Bacitracin B.P.
Prednisolone B.P.............................................................	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. Prednisolone B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Prednisolone Phosphate.................................................	—
Methylprednisolone........................................................	—
Prednisone B.P.................................................................	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Procaine Hydrochloride B.P..........................................	Procaine Hydrochloride B.P. in Normal Saline. Tetracycline and Procaine Injection B.P.
Roserpine B.P. ................................................................	—
Riboflavine B.P................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Sobee.................................................................................	—
Sodium Chloride B.P. with Potassium Chloride B.P. and Hydrated Calcium Chloride in Water for Injection B.P.	Sodium Chloride B.P. with Potassium Chloride B.P., Hydrated Calcium Chloride B.P., Water for Injection B.P. and Dextrose B.P.
Compound Sodium Lactate Injection B.P..................	Compound Sodium Lactate Injection B.P. with Dextrose B.P.
Sodium Lauryl Sulphate B.P.........................................	Emulsifying Wax B.P.
Streptomycin Sulphate B.P............................................	Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Benzylpenicillin Sodium B.P. with Streptomycin Sulphate B.P.

Streptomycin Sulphate B.P. with Normal Saline.
Sulphadimidine B.P........................................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
Sulphamerazine B.P........................................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide
Sulphacetamide...............................................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacctamide

SECOND SCHEDULE—continued.

Pharmaceutical Benefit.		Allowable Compounds (if any).
Sulphathiazole.................................................................		Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
Terpineol B.P...................................................................		Solution of Chloroxylenol B.P.
Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed.......................................................................		Diphtheria Vaccine B.P. with Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed
Tetanus Vaccine B.P......................................................		Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline Hydrochloride B.P...................................		Tetracycline Hydrochloride B.P. with Nystatin
Tetracycline and Procaine Injection B.P.
Tetracycline Hydrochloride B.P. with a buffering agent
Tetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Tetracycline.....................................................................		Tetracycline with Oleandomycin
Thenalidine......................................................................		Thenalidine with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobroma Prepared B.P.C...........................................		Calcium Gluconate B.P. with Sucrose B.P., Vanillin B.P. and Theobroma Prepared B.P.C.
Troxidone B.P..................................................................		—
Typhoid Para-Typhoid A and B Vaccine B.P............		Typhoid Para-Typhoid A, B and C Vaccine B.P.
Tyrothricin........................................................................		Tyrothricin with a buffering agent
Concentrated Vitamin A Solution B.P........................ Concentrated Vitamin D Solution B.P........................		Concentrated Vitamins A and D Solution B.P. Concentrated Vitamins A and D Solution B.P.
Vitamin D.........................................................................		Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Xylene B.P.C. 1949........................................................		Dicophane B.P. with Emulsifying Wax B.P., Xylene B.P.C. 1949,Oil of Citronella and Water
Yellow Mercuric Oxide B.P..........................................		Mercuric Oxide Eye Ointment B.P.
––––––––– THIRD SCHEDULE. Regulation 11. PHARMACEUTICAL BENEFITS ADDITIONAL TO PHARMACEUTICAL BENEFITS IN THE BRITISH PHARMACOPOEIA.
Acetazolamide Sodium.	Aluminium Acetate Solution, B.P.C.
Acetone, B.P.C.	Aluminium Powder.
Acetyl-Sulphamethoxypyridazine.	Amidopyrin, B.P.C.
Aconite Liniment, B.P.C.	Amiphenazole Hydrobromide.
Acriflavine, B.P. 1948.	Amiphenazole Hydrochloride, A.P.F. 1955.
Adrenaline Hydrochloride Solution, B.P. 1953.	Ammonium Acetate, Strong Solution, B.P. 1953.
Adrenaline in Oil.	Ammonium Bicarbonate, B.P. 1953.
Adrenaline Mucate.	Ammonium Bromide, B.P.C.
Agar, B.P.C.	Amphotericin B.
Aloes Pill B.P. 1948.	Amylobarbitone Sodium, B.P.C.
Aloin, B.P. 1953.	Androstanolone.
Aloxidone.

THIRD SCHEDULE—continued.

Aromatic Ammonia Solution, B.P.C.	Dextrochlorpheniramine Maleate.
Aromatic Ammonia Spirit, B.P. 1953.	Dextrose in ⅕ Normal Saline.
Aurothioglucose.	Diethazine Hydrochloride.
Balsam of Peru, B.P.C.	Diethazine Iodide.
Beeswax, Yellow, B.P.C.	Digitoxin, B.P.C.
Belladonna Suppository, B.P. 1948.	Dihydroergotamine.
Bemegride, A.P.F. 1955.	Dihydromorphinone Hydrochloride, B.P.C. 1949
Benzalkonium Chloride.	Dihydrotachysterol.
Benzoinated Lard, B.P.C.	Diphtheria Toxoid Purified.
Bephenium Hydroxynaphthoate.	Disodium Diethylstilboestrol Diphosphate.
Bismuth Carbonate, B.P. 1953.	Disodium Dihydrogen Versenate.
Bismuth Glycollylarsanilate.	Ephedrine Sulphate, B.P.C.
Bismuth Subgallate, B.P. 1953.	Ergot Liquid Extract, B.P.C.
Bismuth Subnitrate, B.P.C.	Erythrityltetranitrate, B.P.C. 1949.
Bretylium Tosylate.	Erythromycin Glucoheptonate.
Buchu Concentrated Infusion, B.P.C.	Erythromycin Propionate.
Busulphan.	Erythromycin Stearate.
Butyl Aminobenzoate, B.P. 1953.	Ether Nitrous Spirit, B.P.C.
Caffeine Citrate, B.P.C.	Ethoxzolamide.
Cajuput Tincture, B.P.C.	Ethylidene Dicoumarin.
Calamine Cream, A.P.F.	Ferric Chloride Solution, B.P.C.
Calcium Aurothiomalate.	Ferrous Phosphate Compound Syrup, B.P.C.
Calcium Di-Oxytetracycline.	Ferrous Phosphate with Quinine and
Calcium Para-Aminosalicylate, B.P.C.	Strychnine Syrup, B.P.C.
Calcium Phosphate. B.P. 1953.	Fludrocortisone Acetate.
Calumba Concentrated Infusion, B.P. 1948	Fluoxymesterone.
Calumba Tincture, B.P. 1948.	Formyl-Tetrahydropteroyl Glutamic Acid.
Capsicum Ointment, B.P.C.	Fructose, B.P. 1948.
Capsicum Tincture, B.P.C.	Gall with Opium Ointment, B.P.C.
Caramiphen Hydrochloride.	Gelesmium Tincture, B.P.C.
Cardamom Aromatic Tincture, B.P.C.	Gentian Violet.
Catechu Tincture, B.P.C.	Glucose Liquid, B.P. 1953.
Charcoal.	Glycerophosphates Compound Syrup, A.P.F.
Chiniofon, B.P. 1948.	Hamamelis Dry Extract.
Chlorambucil.	Heparin Retard.
Chlorazanil.	Hexachlorophene, 3% with Entsufon.
Chlormerodrin.	Hexachlorothiazide.
Chlorpheniramine Maleate.	Hexoestrol.
Chlorpropamide.	Hydrocortisone Sodium Succinate.
Chlortetracycline Calcium.	Hydrocyanic Acid Dilute, B.P.C.
Chlorothiazide.	Hydroflumethiazide.
Clemizole.	Hydroxychloroquine Sulphate.
Cloves, Concentrated Infusion, B.P.C.	Hypophosphorous Acid Dilute, B.P.C.
Codeine, B.P.C.	Insulin Isophane (N.P.H.).
Cod Liver Oil Emulsion, B.P. 1953.	Insulin Special P (Pig).
Colchicine Salicylate.	Iodochlorhydroxyquinoline.
Colocynth and Hyoscyamus Pill, B.P.C.	Iodoform, B.P.C.
Colocynth, B.P.C.	Iodoform Suppository, B.P. 1948.
Colocynth Compound Powder Extract, B.P.C.	Ipomoea Resin.
Compound Effervescent Powder, B.P. 1953	Iron Carbonate Saccharated, B.P.C.
Creosote, B.P. 1953.	Iron Oxide Saccharated.
Crude Coal Tar.	Isoprenaline Hydrochloride.
Cyclophosphamide.	Lobelia Ethereal Tincture, B.P.C.
Cycloserine.	Lofenalac.
Cycrimine Hydrochloride.	Magenta, B.P.C.
D-Cycloserine.	Magnesium Bicarbonate Solution, B.P. 1948.
Darrow’s Solution.	Mecamylamine.
Demethylchlortetracycline Hydrochloride.	Mecholyl Chloride.
Desacetyl-Lanatoside, C.	Mercaptomerin Sodium.
Dexamethasone.	Mercaptopurine.
Dextran Iron.	Mercuric Chloride, B.P. 1953.
Dextrin Iron.

THIRD SCHEDULE—continued.

Mercurous Chloride Ointment, B.P. 1948.	Pyrrolidino-Methyl-Tetracycline.
Mercury Compound Ointment, B.P.C.	Quassia Tincture, B.P. 1948.
Methenamine Mandelate.	Ristocetin.
Methorphinan.	Salicylazosulphapyridine.
Methotrexate.	Senega Concentrated Infusion, B.P.C.
Methyl Androstanolone.	Senna Compound Mixture, B.P.C.
Methyl Atropine Nitrate.	Senna Loaf Concentrated Infusion, B.P.C.
Methyl Prednisolone.	Siberian Fir Oil, B.P.C. 1949.
Methylandrostenediol.	Silver Picrate, B.P.C. 1949.
Myrrh, B.P.C.	Silver Protein Mild, B.P.C.
Myrrh Tincture, B.P.C.	Soap Curd, B.P.C.
Nicoumalone.	Soap Hard, B.P.C.
Nitrofurantoin.	Sobee.
Nitromin.	Sodium Calcium Edetate.
Norethandrolone.	Sodium Carbonate Exsiccated, B.P.C.
Nux Vomica Extract, Dried, B.P. 1953.	Sodium Folate.
Nystatin.	Sodium Lactate.
Oestradiol Dipropionate.	Sodium Nitrite, B.P.C.
Oestrone.	Sodium Oleate Acid.
Oleandomycin.	Sodium Tauroglycocholate.
Oleoresin Capsicum.	Sorbolene, A.P.F.
Orange Peel Infusion Concentrated, B.P. 1948	Spiramycin.
Orange Peel Infusion Concentrated,	Squill Tincture.
Compound, B.P.C.	Squill Vinegar, B.P. 1948.
Ox-Bile Extract, B.P. 1948.	Strophantus Tincture, B.P. 1948.
Oxymel, B.P.C.	Strychnine, B.P.C.
Oxymel of Squill, B.P.C.	Sulphacetamide.
Oxytetracycline I.M.	Sulphadiazine Sodium.
Pancrex 5.	Sulphadimethoxine.
Para-Aminosalicyclic Acid.	Sulphamethoxypyridazine.
Paraben Ophthalmic Phosphate Buffer, A.P.F.	Sulphafurazole.
Paraben Ophthalmic Vehicle, A.P.F.	Sulphamethizole.
Papaveretum, B.P.C.	Sulphaphenazole.
Benzylpenicillin in. Oil.	Sulphathiazole.
Penicillin Benethamine.	Sulphapyridine, B.P.C.
Penicillinase.	Sulphuric Acid Dilute, B.P.C.
Pentaerythritol Tetranitrate.	Sustanon.
Pertussis Prophylactic (Haemagglutinin Aluminium	Syntocinon.
Phosphate Adsorbed).	Talc Purified, B.P.C.
Phemitone, B.P. 1953.	Testosterone Oenanthate.
Phenazone, B.P.C.	Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed.
Phenoxymethylpenicillin (Benzathine Salt).	Tetracycline.
Phenoxymethylpenicillin (Calcium Salt).	Thenalidine.
Phenoxymethylpenicillin (Potassium Salt).	Theobromine, B.P.C.
Phenoxymethylpenicillin (Hydrabamine salt)	Theobroma Prepared, B.P.C.
Phensuximide.	Thiacetazone.
Phenylbutazone.	Thiouracil, B.P. 1948.
Phthalysulphacetamide.	Thyrotropin.
Pholcodine, B.P.C.	Tiger Snake Antivenene.
Pholcodine Citrate Syrup, B.P.C.	Tolbutamide.
Piperazine Citrate.	Tretamine.
Pituitary (Posterior Lobe).	Triethanolamine Trinitrate
Potash Sulphurated, B.P.C.	Triethylene Thiophosphoramide
Potassium Chlorate, B.P.C.	Trimetaphan Camphorsulphonate.
Prednisolone Phosphate.	Trinitrophenol, B.P.C.
Prednisolone Sodium Hemisuccinate.	Tripolidine Hydrochloride.
Probenecid.	Tyrothrycin.
Prophenpyridamine Para-Aminosalicylate.	Valerian Ammoniated Tincture, B.P.C.
Protamine Sulphate.	Vasopressin Tannate in Oil.
Protoveratrines A.	Veriloid.
Pyridostigmine Bromide.	Vitamin A.
Pyridoxine Hydrochloride, B.P.C.	Vitamin D.
Vitamin K.
Xylene, B.P.C. 1949.

8. The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is repealed and the following Schedule inserted in its stead:—

FIFTH SCHEDULE.

Regulation 14.

PHARMACEUTICAL BENEFITS THE PRESCRIBING OF WHICH IS SUBJECT TO CONDITIONS AND RESTRICTIONS.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Amiphenazole Hydrochloride A.P.F. 1955	As an antidote to barbiturate and other hypnotic poisons
Amphotericin B.............................................................	Systemic fungal infections
Aneurine Hydrochloride Tablets B.P.........................	Any disease or condition in a pensioner
Ascorbic Acid Tablets B.P...........................................	Any disease or condition in a pensioner
Bemegride A.P.F. 1955................................................	As an antidote to barbiturate and other hypnotic poisons
Busulphan.......................................................................	The leukaemias
Calciferol Tablets B.P...................................................	Any disease or condition in a pensioner
Calciferol Solution B.P.	Any disease or condition in a child under the age of twelve years or in a pensioner
Calcium Para-Aminosalicylate B.P.C........................	Tuberculosis
Caramiphen Hydrochloride.........................................	Parkinsonism
Chlorambucil..................................................................	Malignant lymphoma and related conditions
Chloramphenicol Capsules B.P...................................	Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate Bacterium coli meningitis, if other forms of treatment are unsuccessful Brucellosis Granuloma inguinale Friedlander bacillus infections Haemophilus influenzae infections Laryngo-tracheo-bronchitis, acute Lymphogranuloma venereum Salmonella infections Staphylococcal infections Surgical conditions of the bowel (pre-operative and post-operative) Typhoid fever Typhus and other rickettsial diseases Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides Whooping cough (Haemophilus pertussis) As an alternative to the Penicillins in a person sensitive to the Penicillins Severe gastro-enteritis in a child under the age of sixteen years
Chloramphenicol B.P., Injection................................	A disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol B.P., Oral Suspension...................	A disease or condition, specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years
Chlortetracycline Capsules B.P...................................	As an alternative to the Penicillins in a person sensitive to the Penicillins Actinomycosis Amoebiasis
Bacterial endocarditis (Streptococcus faccalis), acute and sub-acute

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Chlortetracycline Capsules B.P.—continued.	Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate Bronchiectasis Brucellosis Chancroid Fibrocystic disease of the pancreas Granuloma inguinale Friedlander bacillus infections Leptospirosis Lymphogranuloma venereum Mucoviscidosis Pneumonia that is resistant both to the Penicillins and the Sulphonamides Primary atypical pneumonia Psittacosis Puerperal infections Rat-bite fever (Spirillum minus) Staphylococcal infections Trachoma that is resistant to the Sulphonamides Typhus and other rickettsial diseases Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides Whooping cough (Haemophilus pertussis)
Chlortetracycline Injection B.P....................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Chlortetracycline Calcium Chlortetracycline B.P., Granules	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Cod Liver Oil B.P. Cod Liver Oil Emulsion B.P. 1953 Corticotrophin Injection B.P.........................................	Any disease or condition in a child under the age of twelve years or in a pensioner With the written authority of the Director-General— A disease or condition specified in this column in relation to Cortisone Acetate The treatment of side effects of corticosteroid therapy
Cortisone Injection B.P..................................................	With the written authority of the Director-General— Anaemia, acquired haemolytic Addison’s disease and other forms of adrenocortical hypoplasia Adrenalectomy, total Adrenogenital syndrome Cushing’s syndrome, including hyperadrenocorticalism Dermatitis, acute exfoliative, associated with drug therapy Dermatomyositis Encephalomyelitis Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy Hepatitis, progressive or continuing, proven by biopsy or biochemistry The leukaemias Nephritis, type II. Nephrotic syndrome

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Cortisone Injection B.P.—continued.	Neuro-myelitis optica Optic neuritis following removal of tumor of the brain Panhypopituitarism Pemphigus Periarteritis nodosa Pseudohermaphroditism Purpura, Henoch’s Purpura, thrombocytopenic Rheumatic carditis, acute Sarcoidosis Scleroderma Status asthmaticus Steroid therapy prior to operation in patients under steroid therapy Systemic lupus erythematosus Sympathetic ophthalmitis Ulcerative colitis proven by sigmoidoscopy and radiological report Uveitis, posterior Still’s disease in a child under the age of sixteen years
Cortisone Tablets B.P..................................................... Cyanocobalamin Injection B.P. (other than 1,000 microgramme strength)	A disease or condition specified in this column in relation to Cortisone Injection Established megalocytic anaemias
Cyanocobalamin Injection B.P., 1,000 microgramme strength	Neuroblastoma
Cyclosphosphamide Cycloserine D-Cycloserine Demethylchlortetracycline Hydrochloride	Any disease or condition in a patient receiving treatment in or at an approved hospital A disease or condition specified in this column in relation to Chlortetracycline Capsules
Deoxycortone Acetate B.P. Deoxycortone Acetate Injection B.P. Deoxycortone Acetate Implant B.P.	Addison’s disease Total adrenalectomy
Dexamethasone..............................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Dextran Iron Dextrin Iron Dienoestrol B.P., Cream ............................................... Dienoestrol Tablets B.P.................................................	As an alternative to Oral Iron in a person unable to take Oral Iron Any disease or condition in a pensioner Carcinoma of the prostate Mammary carcinoma Any disease or condition in a pensioner
Dihydrostreptomycin Sulphate Injection B.P.	As an alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Dihydrotachysterol......................................................... Disodium Diethylstilboestrol Diphosphate	Parathyroid deficiency Carcinoma of the prostate
Erythromycin B.P. Erythromycin Tablets B.P. Erythromycin Glucoheptonate Erythromycin Propionate	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Erythromycin B.P., Oral Suspension Erythromycin Stearate, Oral Suspension.......................................................................	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins in a child under the age of twelve years
Ethinyloestradiol Tablets B.P.......................................	Turner’s syndrome Pre-menopausal castration Any disease or condition in a pensioner
Ethisterone Tablets B.P..................................................	Turner’s syndrome Any disease or condition in a pensioner
Fludrocortisone Acetate................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Fluoxymesterone ............................................................ Folic Acid B.P. Folic Acid Tablets B.P. Formyl-Tetrahydropteroyl Glutamic Acid Hexachlorophene, 3% with Entsufon	Mammary carcinoma Macrocytic anaemia Sprue or the sprue-like syndrome Any disease or condition in a patient receiving treatment in or at an approved hospital
Hydrocortisone Injection B.P........................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Sodium Succinate..............................	Acute adrenal failure due to a medical or surgical crisis Stevens Johnson syndrome
Iron Oxide Saccharated.................................................	As an alternative to Oral Iron in a person unable to take Oral Iron
Isoniazid Tablets B.P......................................................

Leprosy Tuberculosis
Lofenalac.........................................................................	With the written authority of the Director-General, phenylketonuria
Malt Extract B.P. Malt Extract with Cod Liver Oil B.P.	Any disease or condition in a child under the age of twelve years or in a pensioner
Mercaptopurine...............................................................	The leukaemias
Methorphinan..................................................................	Inoperable cancer
Methotrexate...................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methyl Androstanolone.................................................	Mammary carcinoma
Methylandrostenediol....................................................	Senile osteoporosis proven by radiography
Mustine Injection B.P.....................................................	Malignant lymphoma and related conditions
Nicotinamide Tablets B.P..............................................	Any disease or condition in a pensioner
Nicotinic Acid Tablets B.P............................................	Any disease or condition in a pensioner
Nitrofurantoin..................................................................	Urinary tract infections
Nitromin............................................................................	Malignant lymphoma and related conditions
Norethandrolone ............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Nystatin............................................................................	Proven monilia infections
Oxytetracycline Tablets B.P. Oxytetracycline Injection B.P. Oxytetracycline and Procaine Injection B.P.	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Oxytetracycline I.M.......................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Calcium Di-Oxytetracycline.........................................	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Pancreatin B.P.................................................................	Fibrocystic disease of the pancreas
Pancrex 5..........................................................................	Pancreatico-duodenectomy Fibrocystic disease of the pancreas
Para-Aminosalicyclic Acid............................................	Pancreatico-duodenectomy Tuberculosis

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Phenoxymethylpenicillin B.P., Oral Suspension Phenoxymethylpenicillin (Benzathine Salt), Oral Suspension Phenoxymethylpenicillin(Calcium Salt), Oral Suspension Phenoxymethylpenicillin(Hydrabamine Salt), Oral Suspension Phenoxymethylpenicillin (Potassium Salt), Oral Suspension	Any disease or condition in a child under the age of twelve years
Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Phenylbutazone............................................................	Any disease or condition in a pensioner
Prednisolone Tablets B.P. Methyl Prednisolone Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Prednisolone Sodium Hemisuccinate	Any disease or condition in a patient receiving treatment in or at an approved hospital
Prednisone Tablets B.P. Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone injection
Progesterone Injection B.P. .......................................	Habitual abortion
Protoveratrines A..........................................................	Hypertensive crisis
Pyridostigmine Bromide.............................................	Myasthenia gravis
Quinine Dihydrochloride B.P. Quinine Dihydrochloride Injection B.P. Riboflavine Tablets B.P. ............................................ Ristocetin.......................................................................	Malaria Any disease or condition in a pensioner Any disease or condition in a pensioner Any disease or condition in a patient receiving treatment in or at an approved hospital
Salicylazosulphapyridine	Ulcerative colitis
Sobee	With the written authority of the Director-General, galactosaemia
Sodium Aminosalicylate B.P. Sodium Aminosalicylate Tablets B.P.	Tuberculosis
Sodium Folate ..............................................................	Macrocytic anaemia Sprue or the sprue-like syndrome
Stilboestrol B.P. Stilboestrol Tablets B.P.	Carcinoma of the prostate Mammary carcinoma Any disease or condition in a pensioner
Streptomycin Sulphate B.P.........................................	Bacillary dysentery that is resistant to the Sulphonamides Brucellosis Chancroid Endocarditis due to Streptococcus faecalis or Streptococcus viridans Friedlander bacillus infections Haemophilus influenzae infections Plague Pseudomonas pyocyaneus infections Rat-bite fever (Streptobacillus moniliformis) Salmonella infections Surgical conditions of the bowel (pre-operative and post-operative)

FIFTH SCHEDULE—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Streptomycin Sulphate B.P.—continued.	Surgical conditions of the thoracic organs Tuberculosis Tularaemia Urinary tract infections that are resistant to the Sulphonamides
Streptomycin Sulphate Injection B.P...........................	A disease or condition specified in this column in relation to Streptomycin Sulphate
Streptomycin Sulphate B.P. with Benzylpenicillin Sodium. B.P.	Endocarditis duo to Streptococcus faecalis or Streptococcus viridans
Sustanon...........................................................................	Castration Mammary carcinoma
Testosterone Implants B.P. Testosterone Oenanthate Testosterone Propionate Injection B.P. Testosterone Propionate B.P. Methyltestosterone Tablets B.P.	Castration Kline felter Reinfenstein Albright syndrome Mammary carcinoma
Tetracycline Capsules B.P. Tetracycline Tablets B.P. Tetracycline and Procaine Injection B.P. Tetracycline Hydrochloride B.P. with a buffering agent—Capsules Tetracycline with Oleandomycin Capsules Pyrrolidino-Methyl-Tetracycline	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Tetracycline Hydrochloride B.P. Tetracycline Hydrochloride B.P. with a buffering agent—Oral Suspension Tetracycline Hydrochloride B.P. with a buffering agent—Paediatric Drops Tetracycline with Oleandomycin—Oral Suspension	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Tetracycline Hydrochloride B.P. with Nystatin	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules
Thyrotropin Triethylene Thiophosphoramide	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tretamine.........................................................................	Malignant lymphoma and related conditions
Trimetaphan Camphorsulphonate...............................	Hypotensive for anaesthesia
Veriloid..............................................................................	Hypertensive crisis
Vitamin A Activity with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid P.P. and Vitamin D	Any disease or condition in a pensioner
Concentrated Vitamin A Solution B.P. Concentrated Vitamin A and D Solution B.P.	Any disease or condition in a child under the age of twelve years or in a pensioner
Concentrated Vitamin D Solution
Vitamin K1........................................................................	As an antidote to anticoagulants

____________________

By Authority: A. J. ARTHUR, Commonwealth Government Printer, Canberra.

Actions

Download as PDF Download as Word Document

Citations

National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0